# Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia

> **NCT00140413** · PHASE4 · COMPLETED · sponsor: **Children's Hospital Los Angeles** · enrollment: 20 (actual)

## Conditions studied

- Growth Hormone Deficiency
- Septo-Optic Dysplasia
- Hypopituitarism

## Interventions

- **DRUG:** Nutropin AQ

## Key facts

- **NCT ID:** NCT00140413
- **Lead sponsor:** Children's Hospital Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140413, "Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00140413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*